Accessibility Menu
 

Olympus

(OTC) OLYMY

Current Price$9.77
Market Cap$10.75B
Since IPO (1995)+360%
5 Year-54%
1 Year-24%
1 Month+11%

Olympus Financials at a Glance

Market Cap

$10.75B

Revenue (TTM)

$936.33B

Net Income (TTM)

$132.32B

EPS (TTM)

$0.50

P/E Ratio

19.47

Dividend

$0.14

Beta (Volatility)

0.56 (Low)

Price

$9.77

Volume

42,997

Open

$9.96

Previous Close

$9.76

Daily Range

$9.77 - $9.96

52-Week Range

$8.08 - $14.55

OLYMY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Olympus

Industry

Healthcare Equipment and Supplies

Employees

29,297

CEO

Robert White, MBA

Headquarters

Hachioji, 192-8507, JP

OLYMY Financials

Key Financial Metrics (TTM)

Gross Margin

66%

Operating Margin

16%

Net Income Margin

9%

Return on Equity

12%

Return on Capital

15%

Return on Assets

6%

Earnings Yield

5.14%

Dividend Yield

0.00%

Payout Ratio

26.59%

Stock Overview

Market Cap

$10.75B

Shares Outstanding

1.10B

Volume

43.00K

Short Interest

0.00%

Avg. Volume

135.06K

Financials (TTM)

Gross Profit

$683.70B

Operating Income

$162.46B

EBITDA

$232.37B

Operating Cash Flow

$190.46B

Capital Expenditure

$65.21B

Free Cash Flow

$125.25B

Cash & ST Invst.

$254.83B

Total Debt

$229.10B

Olympus Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$247.84B

+15.8%

Gross Profit

$161.30B

+17.6%

Gross Margin

65.08%

N/A

Market Cap

$10.75B

N/A

Market Cap/Employee

$366.81K

N/A

Employees

29,297

N/A

Net Income

$20.20B

-19.0%

EBITDA

$33.18B

-43.9%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$66.77B

+30.2%

Accounts Receivable

$190.99B

N/A

Inventory

$208.61B

+11.6%

Long Term Debt

$233.87B

-31.4%

Short Term Debt

$0.00

-100.0%

Return on Assets

5.82%

N/A

Return on Invested Capital

14.54%

N/A

Free Cash Flow

$29.64B

-6.5%

Operating Cash Flow

$48.64B

+4.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ODTCOdonate Therapeutics, Inc.
$22005.00+29.44%
ESALYEisai Co., Ltd.
$61.51-2.11%
NPRRFNipro Corporation
$9.96+0.00%
BITGFBiotage AB (publ)
$15.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.91-0.04%
FCUVFocus Universal
$6.55+0.96%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.38+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$76.72-0.01%

Questions About OLYMY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.